News Center
With the tenet of "Healthy China, Dedicated commitment", Linuo Pharmaceuticals increases cooperation and association with external scientific research institutes while innovating and developing independently.
04
2023
-
12
Building a Learning Team (Lesson 2) | lino pharmaceutical participates in the training of drug safety emergency public opinion management ability of the provincial food and drug administration!
Classification：
News
Corporate News
In order to further standardize the emergency disposal workflow, timely and securely dispose of all kinds of emergency situations in the drug production process, and effectively deal with the risk of public opinion in drug production,Shandong Provincial Drug Administration held a training meeting on the ability of drug safety emergency public opinion management in Shandong Province.Shandong Linuo Pharmaceutical Co., Ltd. actively participates in improving the emergency handling capacity of enterprises and helping high-quality and stable development.
As a pharmaceutical company focusing on the development, production and sales of drugs in the field of chronic diseases,LiNuo Pharmaceuticals actively fulfill its corporate social responsibilityWe attach great importance to drug safety and public opinion management.
Through this training,Greatly enhance the professionalism of the lino pharmaceutical team,Strengthened the team's understanding of drug safety emergency management,The emergency response capacity of the team has been improved,Better respond to emergencies and public opinion risks.
linuo pharmaceutical will apply what we have learned from this training to practical work to build a learning team,Adhere to the people's health as the center, further improve the drug safety emergency management system,Continuously improve their own management level and technical strength,To provide safer and more effective pharmaceutical products for the society,To protect public health.
Related news
2026-05-18
On May 16–17, Wu Xiaobo, known as “China’s foremost financial writer” and a renowned entrepreneur, led a delegation to visit and inspect Keyuan Pharmaceutical (stock code: 301281.SZ). The group focused on the company’s achievements in integrating smart manufacturing with digital AI technologies in the pharmaceutical sector, engaged in in-depth discussions with its core management team, and expressed high praise for the company’s practical approach to driving industrial upgrading through digital and intelligent transformation. Gao Yuankun, Chairman and President of Linuo Group, along with Li Hongfu, Chairman of Keyuan Pharmaceutical, and Wei Zhiguo, President of the company, accompanied the delegation during the visit.
ADD：#30766 Jingshidong Road, Linuo High-tech Park, Jinan, Shandong Province, P. R. China